 |
|
|
| |
Switching to Islatravir + Ulonivirine Once Weekly Maintained HIV-1 Viral Suppression at Week 24 in the Presence of Baseline Nonnucleoside Reverse Transcriptase Inhibitor Resistance-Associated Mutations and M184I/V in Proviral DNA
|
| |
| |
IDSA Oct 21-24 Wash DC
Islam T. M. Hussein; Tracy L. Diamond; Uchechukwu Nwoke; Uche Okoro; Yayun (Alice) Xu; Kim Beckey; Randolph P. Matthews; Mengchun Li; Ernest Asante-Appiah
Merck & Co., Inc., Rahway, NJ, USA
|
| |
|
|
|
|
|
